期刊
BRAIN SCIENCES
卷 10, 期 9, 页码 -出版社
MDPI
DOI: 10.3390/brainsci10090606
关键词
NPS; sex; gender differences; cannabinoids; cathinones; phenethylamines; opioids; new synthetic drugs
资金
- Autonomous Region of Sardinia (RAS-FSC 2018) [RC_CRP_034, CUP RASSR03071]
- Ministry of Education, University and Research (MIUR) (PRIN 2017) [2017SXEXT5]
- Department of Anti-Drug Policies, of the Presidency of the Council of Ministers, Italy
- University of Ferrara
- European Commission under the Call JUST-2017-AG-DRUG SUPPORTING INITIATIVES IN THE FIELD OF DRUGS POLICY), JUST-2017-AG-DRUG [806996-JUSTSO]
Sex and gender deeply affect the subjective effects and pharmaco-toxicological responses to drugs. Men are more likely than women to use almost all types of illicit drugs and to present to emergency departments for serious or fatal intoxications. However, women are just as likely as men to develop substance use disorders, and may be more susceptible to craving and relapse. Clinical and preclinical studies have shown important differences between males and females after administration of classic drugs of abuse (e.g., Delta 9-tetrahydrocannabinol (THC), morphine, cocaine). This scenario has become enormously complicated in the last decade with the overbearing appearance of the new psychoactive substances (NPS) that have emerged as alternatives to regulated drugs. To date, more than 900 NPS have been identified, and can be catalogued in different pharmacological categories including synthetic cannabinoids, synthetic stimulants (cathinones and amphetamine-like), hallucinogenic phenethylamines, synthetic opioids (fentanyls and non-fentanyls), new benzodiazepines and dissociative anesthetics (i.e., methoxetamine and phencyclidine-derivatives). This work collects the little knowledge reached so far on the effects of NPS in male and female animal and human subjects, highlighting how much sex and gender differences in the effects of NPS has yet to be studied and understood.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据